Lv11
60 积分 2024-03-15 加入
A YEAR'S COMPARISON OF TREATMENT OF PATIENTS WITH PARKINSON'S DISEASE WITH LEVODOPA COMBINED WITH CARBIDOPA VERSUS TREATMENT WITH LEVODOPA ALONE
6小时前
求助中
Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects
11小时前
已完结
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
2个月前
已完结
Systemic Distribution and Tumor Localization of Adoptively Transferred Lymphocytes in Mice: Comparison with Physiologically Based Pharmacokinetic Model
3个月前
已完结
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
4个月前
已关闭
Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy
7个月前
已完结
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
8个月前
已完结
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
9个月前
已完结
皖公网安备34019202002308
